Bladder cancer, version 3.2020, NCCN clinical practice guidelines in oncology

TW Flaig, PE Spiess, N Agarwal, R Bangs… - Journal of the National …, 2020 - jnccn.org
This selection from the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines)
for Bladder Cancer focuses on the clinical presentation and workup of suspected bladder …

Optimizing cystoscopy and TURBT: enhanced imaging and artificial intelligence

E Shkolyar, SR Zhou, CJ Carlson, S Chang… - Nature Reviews …, 2024 - nature.com
Diagnostic cystoscopy in combination with transurethral resection of the bladder tumour are
the standard for the diagnosis, surgical treatment and surveillance of bladder cancer. The …

Clinical and cost effectiveness of hexaminolevulinate-guided blue-light cystoscopy: evidence review and updated expert recommendations

JA Witjes, M Babjuk, P Gontero, D Jacqmin, A Karl… - European urology, 2014 - Elsevier
Context Non–muscle-invasive bladder cancer (NMIBC) is associated with a high recurrence
risk, partly because of the persistence of lesions following transurethral resection of bladder …

[HTML][HTML] Blue light cystoscopy for the diagnosis of bladder cancer: Results from the US prospective multicenter registry

S Daneshmand, ST Bazargani, TJ Bivalacqua… - … Oncology: Seminars and …, 2018 - Elsevier
Introduction Blue light cystoscopy (BLC) using hexaminolevulinate (HAL/Cysview/Hexvix)
has been previously shown to improve detection of non–muscle-invasive bladder cancer …

Hexaminolevulinate blue-light cystoscopy in non-muscle-invasive bladder cancer: review of the clinical evidence and consensus statement on appropriate use in the …

S Daneshmand, AK Schuckman, BH Bochner… - Nature Reviews …, 2014 - nature.com
Hexaminolevulinate (HAL) is a tumour photosensitizer that is used in combination with blue-
light cystoscopy (BLC) as an adjunct to white-light cystoscopy (WLC) in the diagnosis and …

A network meta-analysis of therapeutic outcomes after new image technology-assisted transurethral resection for non-muscle invasive bladder cancer: 5 …

JY Lee, KS Cho, DH Kang, HD Jung, JK Kwon, CK Oh… - BMC cancer, 2015 - Springer
Background This study included a network meta-analysis of evidence from randomized
controlled trials (RCTs) to assess the therapeutic outcome of transurethral resection (TUR) in …

Current status of photodynamic technology for urothelial cancer

K Inoue, H Fukuhara, S Yamamoto… - Cancer …, 2022 - Wiley Online Library
Aminolevulinic acid is a new‐generation photosensitizer with high tumor specificity. It has
been used successfully in the diagnosis, treatment, and screening of urological cancers …

Systematic review and meta-analysis on the impact of hexaminolevulinate-versus white-light guided transurethral bladder tumor resection on progression in non …

G Gakis, O Fahmy - Bladder Cancer, 2016 - content.iospress.com
Introduction: Although there is evidence that hexaminolevulinate (HAL)-based transurethral
bladder tumor resection (TURBT) improves the detection of Ta-T1 non-muscle-invasive …

Comparison of hexaminolevulinate (HAL)-guided versus white light transurethral resection for NMIBC: A systematic review and meta-analysis of randomized …

H Zhao, P Peng, Z Luo, H Liu, J Sun, X Wang… - Photodiagnosis and …, 2023 - Elsevier
Purpose We systematically reviewed the effectiveness of hexaminolevulinic acid (HAL) after
traditional light cystoscopy vs. only white light cystoscopy (WLC) on nonmuscle-invasive …

[图书][B] Imaging in photodynamic therapy

MR Hamblin, Y Huang - 2017 - books.google.com
This book covers the broad field of cellular, molecular, preclinical, and clinical imaging either
associated with or combined with photodynamic therapy (PDT). It showcases how this …